Compare · BRLI vs TENK
BRLI vs TENK
Side-by-side comparison of Brilliant Acquisition Corporation (BRLI) and TenX Keane Acquisition (TENK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BRLI and TENK operate in Blank Checks (Finance), so they compete in similar markets.
BRLI
Brilliant Acquisition Corporation
Brilliant Acquisition Corporation operates as a blank check company. It focuses on acquiring; engaging in share exchange and share reconstruction; purchasing the assets; entering into contractual arrangements; and engaging in similar business combination with one or more businesses. The company was founded in 2019 and is based in Shanghai, China.
Latest BRLI
- SEC Form SC 13G filed by Brilliant Acquisition Corporation
- Brilliant Acquisition Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Brilliant Acquisition Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Brilliant Acquisition Corporation filed SEC Form 8-K: Other Events
- Brilliant Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure
- SEC Form NT 10-K filed by Brilliant Acquisition Corporation
- SEC Form 25-NSE filed by Brilliant Acquisition Corporation
- Nukkleus Inc. Closes Merger with Brilliant Acquisition Corporation
- Brilliant Acquisition Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure
- Brilliant Acquisition Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Latest TENK
- Amendment: SEC Form SC 13D/A filed by TenX Keane Acquisition
- SEC Form 4 filed by Director Dutia Suren G
- SEC Form 4 filed by Director Holubiak Myron Z
- SEC Form 4 filed by Chief Medical Officer Czuczman Myron
- SEC Form 4 filed by Chief Executive Officer Mazur Leonard L
- SEC Form 4 filed by Chief Financial Officer Bartushak Jaime
- SEC Form 4 filed by Director Mcgrath Dennis M
- SEC Form 4 filed by Large owner Citius Pharmaceuticals, Inc.
- SEC Form 4 filed by Director Webb Carol
- SEC Form 3 filed by new insider Dutia Suren G